statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTLT, HRT, SWAV, MODN SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTLT, HRT, SWAV, MODN PR Newswire NEW YORK, May 2, 2024 NEW...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTLT, HRT, SWAV, MODN

NurPhoto / Contributor / Getty Images

 Key TakeawaysNovo Nordisk reported first-quarter earnings that beat analysts' estimates.The Danish drugmaker saw demand continue to rise for its weight-loss...

Novo Nordisk's Earnings Beat Estimates on Surging Demand for Its Weight-Loss Drugs

News of the day for May 2, 2024

 Catherine Leblanc / Getty Images

US stock futures are rising amid a flurry of earnings reports and following Federal Reserve Chair Jerome Powell's comments...

5 Things to Know Before the Stock Market Opens

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVLY, ANSS, CTLT SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVLY, ANSS, CTLT PR Newswire NEW YORK, April 29, 2024 NEW YORK...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVLY, ANSS, CTLT

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTLT, HRT, SCX SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTLT, HRT, SCX PR Newswire NEW YORK, April 18, 2024 NEW YORK, April...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTLT, HRT, SCX

Shareholder rights law firm Robbins LLP informs investors it is investigating the acquisition of Catalent, Inc. (NYSE: CTLT) by Novo Holdings, a holding and investment company that is responsible for...

Robbins LLP Reminds Stockholders it is Investigating the Acquisition of Catalent, Inc. (CTLT)

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger - BCEL, CTLT, NS, SCX SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger...

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger - BCEL, CTLT, NS, SCX

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVLY, CTLT, SCX, KTRA SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVLY, CTLT, SCX, KTRA PR Newswire NEW YORK, April 11, 2024 NEW...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVLY, CTLT, SCX, KTRA

StockNews.com began coverage on shares of Catalent (NYSE:CTLT - Free Report) in a research note published on Wednesday. The firm issued a sell rating on the stock. A number of other brokerages have...

Catalent (NYSE:CTLT) Now Covered by StockNews.com

Bankruptcy filings in the healthcare sector rose significantly over the last three years, rising from 25 in 2021 to 46 in 2022 and 79 in 2023, which was the highest level in five years, according to...

Essential drugmaker to sell, liquidate in Chapter 11 bankruptcy

Catalent, Inc. is a holding company, which engages in the provision of delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. It operates through the following segments: Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment offers formulation, development, and manufacturing services for soft capsules or softgels, as well as large-scale production of oral solid dose forms for pharmaceutical and consumer health markets and supporting ancillary services. The Biologics segment develops and produces biologic cell-line, cell therapy, and viral vector gene therapy, formulation for parenteral dose forms, which include prefilled syringes, vials, and cartridges, and analytical development and testing services for large molecules. The Oral and Specialty Delivery segment is composed of advanced formulation of a range of technologies along with integrated downstream clinical development and commercial supply solutions. The Clinical Supply Services segment is involved in packaging, storage, distribution, and inventory management of drugs and biologics in clinical trials. The company was founded in 1933 and is headquartered in Somerset, NJ.

Volume	1.71M
52-Wk High	$60.20
52-Wk Low	$31.45

Period	Estimated	Reported	Surprise	Result
Q3'24	$0.22	--	--	N/A
Q2'24	-$0.02	-$0.24	-1030.53%	MISSED
Q1'24	-$0.14	-$0.10	26.74%	BEAT
Q4'23	$0.11	$0.09	-17.52%	MISSED
Q3'23	-$0.07	-$0.09	-27.90%	MISSED

CTLT Catalent Inc.

About

Feed

News

Sentiment

Earnings

Fundamentals